These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14007013)

  • 21. [Antithrombotic effects of butazolidin].
    STAMM H
    Geburtshilfe Frauenheilkd; 1958 Nov; 18(11):1354-60. PubMed ID: 13609888
    [No Abstract]   [Full Text] [Related]  

  • 22. [Butazolidin as an antithrombotic agent].
    BOBEK K; CEPELAK V
    Gynaecologia; 1958 Jun; 145(6):434-44. PubMed ID: 13548623
    [No Abstract]   [Full Text] [Related]  

  • 23. [2 Years experience with butazolidin].
    BUCHMULLER W
    Medizinische; 1958 Apr; 12(14):569. PubMed ID: 13540797
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary clinical report on delta-butazolidin (geigy).
    MORIARTY MA
    J Ir Med Assoc; 1959 Apr; 44(262):114-6. PubMed ID: 13641845
    [No Abstract]   [Full Text] [Related]  

  • 25. Inactivation of alpha1-antiproteinase induced by phenylbutazone: participation of peroxyl radicals and hydroperoxide.
    Muraoka S; Miura T
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):261-6. PubMed ID: 16930300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses.
    Fradette ME; Céleste C; Richard H; Beauchamp G; Laverty S
    Am J Vet Res; 2007 Feb; 68(2):128-33. PubMed ID: 17269876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined use of butazolidin (phenylbutazone) and some corticosteroids in experimental inflammations].
    WILHELMI G
    Schweiz Med Wochenschr; 1958 Feb; 88(8):185-8. PubMed ID: 13543303
    [No Abstract]   [Full Text] [Related]  

  • 28. The metabolic fate of phenylbutazone (butazolidin) in man.
    BURNS JJ; ROSE RK; GOODWIN S; REICHENTHAL J; HORNING EC; BRODIE BB
    J Pharmacol Exp Ther; 1955 Apr; 113(4):481-9. PubMed ID: 14368518
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenylbutazone (butazolidin) in the treatment of various rheumatic disorders.
    WORNOM PH; SWINEFORD O
    Va Med Mon (1918); 1955 Apr; 82(4):176-81. PubMed ID: 14374232
    [No Abstract]   [Full Text] [Related]  

  • 30. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.
    BURNS JJ; ROSE RK; CHENKIN T; GOLDMAN A; SCHULERT A; BRODIE BB
    J Pharmacol Exp Ther; 1953 Nov; 109(3):346-57. PubMed ID: 13109696
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preliminary report on evaluation of the liver tolerance of a new antiphlogistic substance (G27, 202)].
    GIGGLBERGER H
    Praxis; 1960 Dec; 49():1233. PubMed ID: 13705198
    [No Abstract]   [Full Text] [Related]  

  • 32. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
    Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
    Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of 14-deoxyandrographolide on calcium-mediated rat uterine smooth muscle contractility.
    Burgos RA; Loyola M; Hidalgo MA; Labranche TP; Hancke JL
    Phytother Res; 2003 Nov; 17(9):1011-5. PubMed ID: 14595578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental studies on influencing antibody formation by butazolidin].
    ROTHER K; KATZ F
    Arch Int Pharmacodyn Ther; 1957 Oct; 112(1-2):65-72. PubMed ID: 13498839
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapeutic and pharmacological properties of the sodium salts of m-aminosalicylic acid].
    DESPERAK-NACIAZEK A; JAKIMOWSKA K; JANOWIEC M; KRYSICKA-DOCZKAL H; PAWLIKOWSKI L; VENULET J
    Med Dosw Mikrobiol; 1963; 15():85-90. PubMed ID: 14027290
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
    Reed SK; Messer NT; Tessman RK; Keegan KG
    Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analgesic activity of the aqueous extract from Ximenia Americana].
    Soro TY; Traore F; Sakande J
    C R Biol; 2009 Apr; 332(4):371-7. PubMed ID: 19304267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial replacement of NaCl can be achieved with potassium, magnesium and calcium salts in brown bread.
    Charlton KE; MacGregor E; Vorster NH; Levitt NS; Steyn K
    Int J Food Sci Nutr; 2007 Nov; 58(7):508-21. PubMed ID: 17852502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid positions 69-132 of UGT1A9 are involved in the C-glucuronidation of phenylbutazone.
    Nishiyama T; Fujishima M; Masuda Y; Izawa T; Ohnuma T; Ogura K; Hiratsuka A
    Arch Biochem Biophys; 2008 Oct; 478(1):75-80. PubMed ID: 18602884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.